Switch to: References

Add citations

You must login to add citations.
  1. A "Queen of Hearts" trial of organ markets: why Scheper-Hughes's objections to markets in human organs fail.J. S. Taylor - 2007 - Journal of Medical Ethics 33 (4):201-204.
    Nancy Scheper-Hughes is one of the most prominent critics of markets in human organs. Unfortunately, Scheper-Hughes rejects the view that markets should be used to solve the current shortage of transplant organs without engaging with the arguments in favour of them. Scheper-Hughes’s rejection of such markets is of especial concern, given her influence over their future, for she holds, among other positions, the status of an adviser to the World Health Organization on issues related to global transplantation. Given her influence, (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Unjust organ markets and why it is irrelevant that selling a kidney is the best option.Andreas Albertsen - forthcoming - Journal of Medical Ethics.
    An important argument against prohibiting organ sales is that it removes the best option available to individuals in dire circumstances. However, this line of reasoning fails to recognise that selling a kidney on a regulated market is only the best option in a very narrow comparison, where a regulated organ market is compared with banning organ sales. Once we acknowledge this narrowness, selling a kidney is not the best option. This paves the way for a distributive justice-based critique of the (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation